Josef W. Goldufsky

Josef W. Goldufsky

Auto-generated profile, based on publicly available information

Josef W. Goldufsky

Department of Medicine, Rush University Medical Center, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
RSRyan T. Sowell
Ryan T. Sowell
JGJosef W. Goldufsky
Josef W. Goldufsky
MRMagdalena Rogozinska
Magdalena Rogozinska
ZQZurisaday Quiles
Zurisaday Quiles
YCYanxia Cao
Yanxia Cao
Amanda L MarzoAmanda L Marzo
Amanda L Marzo
IL-15 is an essential cytokine known to promote T cell survival and activate the effector function of memory phenotype CD8 T cells. Blocking IL-15 signals also significantly impacts tissue-specific effector and memory CD8 T cell formation. In this study, we demonstrate that IL-15 influences the generation of memory CD8 T cells by first promoting their accumulation into mucosal tissues and second by sustaining expression of Bcl-6 and T-bet. We show that the mechanism for this recruitment is largely dependent on mammalian target of rapamycin and its subsequent inactivation of FoxO1. Last, we show that IL-15 complexes delivered locally to mucosal tissues without reinfection is an effective strategy to enhance establishment of tissue resident memory CD8 T cells within mucosal tissues. This study provides mechanistic insight into how IL-15 controls the generation of memory CD8 T cells and influences their trafficking and ability to take up residence within peripheral tissues.

6 February 2020 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
OKOmer E. Kaymakcalan
Omer E. Kaymakcalan
AAAndrew Abadeer
Andrew Abadeer
JGJosef W. Goldufsky
Josef W. Goldufsky
UGUri Galili
Uri Galili
SKSarah J. Karinja
Sarah J. Karinja
JSJason A. Spector
Jason A. Spector

1 August 2016 in Journal of Medical Microbiology
Verified
Journal Article
Open access
JKJeffrey S. Kroin
Jeffrey S. Kroin
JLJinyuan Li
Jinyuan Li
JGJosef W. Goldufsky
Josef W. Goldufsky
KGKajal Gupta
Kajal Gupta
MMMasoomeh Moghtaderi
Masoomeh Moghtaderi
Sasha H ShafikhaniSasha H Shafikhani
Sasha H Shafikhani
Surgical site infection (SSI) remains one of the most important causes of healthcare-associated infections, accounting for ~17 % of all hospital-acquired infections. Although short-term perioperative treatment with high fraction of inspired oxygen (FiO2) has shown clinical benefits in reducing SSI in colorectal resection surgeries, the true clinical benefits of FiO2 therapy in reducing SSI remain unclear because randomized controlled trials on this topic have yielded disparate results and inconsistent conclusions. To date, no animal study has been conducted to determine the efficacy of short-term perioperative treatments with high (FiO2>60 %) versus low (FiO2<40 %) oxygen in reducing SSI. In this report, we designed a rat model for muscle surgery to compare the effectiveness of short-term perioperative treatments with high (FiO2=80 %) versus a standard low (FiO2=30 %) oxygen in reducing SSI with Pseudomonas aeruginosa – one of the most prevalent Gram-negative pathogens, responsible for nosocomial SSIs. Our data demonstrate that 5 h perioperative treatment with 80 % FiO2 is significantly more effective in reducing SSI with P. aeruginosa compared to 30 % FiO2 treatment. We further show that whilst 80 % FiO2 treatment does not affect neutrophil infiltration into P. aeruginosa-infected muscles, neutrophils in the 80 % FiO2-treated and infected animal group are significantly more activated than neutrophils in the 30 % FiO2-treated and infected animal group, suggesting that high oxygen perioperative treatment reduces SSI with P. aeruginosa by enhancing neutrophil activation in infected wounds.